Case Study: Rezo accelerates drug discovery and saves over 90% on compute costs with Union.ai

Rezo saves over 90% on compute costs with Union.ai

Rezo, a growth-stage biotech company, faced significant challenges in scaling its early-stage drug discovery. Their work required running high-throughput, compute-intensive workloads like AlphaFold for protein modeling, but they needed to do so cost-efficiently without increasing operational overhead or hiring dedicated DevOps staff. They turned to the vendor Union.ai and its Flyte AI development platform to overcome these barriers.

Union.ai implemented a tailored solution that enabled Rezo to dynamically scale across hundreds of TPUs and leverage discounted spot instances without risk of interruption. The platform also helped fine-tune infrastructure, using esoteric CPU instances and on-the-fly SSD provisioning to drastically cut costs. As a result, Rezo achieved up to 90% savings on storage and 67% on compute, accelerated its drug discovery pipeline, and eliminated the need for additional DevOps hiring, all through its partnership with Union.ai.

Rezo